Description

2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid is a high-purity, bile acid-derived sulfonic acid compound of significant interest in advanced biochemical research and pharmaceutical development. Its unique structure, featuring a steroidal core conjugated with an ethanesulfonic acid moiety, makes it a valuable intermediate for synthesizing novel therapeutic agents and diagnostic probes. This compound is essential for researchers and manufacturers in the life sciences sector focusing on metabolic pathways, liver function studies, and the development of targeted drug delivery systems.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of novel steroidal drugs and bile acid analogs with potential therapeutic applications.
• Biochemical Research: Used as a reference standard or probe in studies of bile acid metabolism, hepatobiliary function, and membrane transport mechanisms.
• Diagnostic Agent Development: Serves as a precursor for developing contrast agents or biomarkers for medical imaging, particularly related to liver and intestinal function.
• Enzyme Inhibition Studies: Investigated for its potential role as an inhibitor in enzymatic pathways involving sulfonation or sterol metabolism.
• Cholesterol Metabolism Research: A critical tool for studying the interaction between bile acid derivatives and cholesterol homeostasis.
• Academic & Institutional R&D: Supplied to universities and research institutes for fundamental chemical and biological research projects.

Basic Information

Product Name	2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
CAS No.	25696-60-0
Molecular Formula	C₂₆H₄₃NO₇S
Molecular Weight	513.69 g/mol
Synonyms	3α,7α,12α-Trihydroxy-5β-cholan-24-oyltaurine; Taurocholic Acid Impurity; Taurocholic Acid Related Compound; N-[(3α,5β,7α,12α)-3,7,12-Trihydroxy-24-oxocholan-24-yl]taurine; 2-[(3α,7α,12α-Trihydroxy-24-oxo-5β-cholan-24-yl)amino]ethanesulfonic acid; Taurine conjugate of 3α,7α,12α-trihydroxy-5β-cholanic acid; Tauro-3α,7α,12α-trihydroxy-5β-cholanate
EINECS	Contact for details

Quality Control

Our 2-[[(4R)-4-[(3R,5R,6S,7R,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for research and development. Certificates of Analysis (COA) with detailed batch-specific data are available upon request to support your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent product degradation. For long-term storage, consider desiccants or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Related Substances (HPLC)	Total impurities ≤ 3.0% Any single impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.